loadpatents
Patent applications and USPTO patent grants for Parkinson; John.The latest application filed is for "safe logon".
Patent | Date |
---|---|
Privacy scout Grant 11,436,364 - Parkinson , et al. September 6, 2 | 2022-09-06 |
Unsubscribe and delete automation Grant 11,374,889 - Parkinson , et al. June 28, 2 | 2022-06-28 |
Diamine derivatives as inhibitors of leukotriene A4 hydrolase Grant 11,267,819 - Arnaiz , et al. March 8, 2 | 2022-03-08 |
Safe Logon App 20220060466 - Parkinson; John ;   et al. | 2022-02-24 |
Embedded Virtual Private Network App 20220029966 - Park; Jason ;   et al. | 2022-01-27 |
Unsubscribe and Delete Automation App 20210385181 - Parkinson; John ;   et al. | 2021-12-09 |
Unsubscribe automation Grant 11,196,693 - Parkinson December 7, 2 | 2021-12-07 |
Safe logon Grant 11,196,734 - Parkinson , et al. December 7, 2 | 2021-12-07 |
Embedded virtual private network Grant 11,190,490 - Park , et al. November 30, 2 | 2021-11-30 |
Authenticating Devices Via Tokens And Verification Computing Devices App 20210359992 - Parkinson; John ;   et al. | 2021-11-18 |
Authenticating devices via one or more pseudorandom sequences and one or more tokens Grant 11,044,244 - Parkinson , et al. June 22, 2 | 2021-06-22 |
Digital Footprint Visual Navigation App 20210144231 - Park; Jason ;   et al. | 2021-05-13 |
Safe Logon App 20210029107 - Parkinson; John ;   et al. | 2021-01-28 |
Digital footprint visual navigation Grant 10,887,425 - Park , et al. January 5, 2 | 2021-01-05 |
Modular Production Line And Process For Using It App 20200337331 - Chong; Peng-Siong ;   et al. | 2020-10-29 |
Unsubscribe Automation App 20200336449 - Parkinson; John | 2020-10-22 |
Diamine Derivatives As Inhibitors Of Leukotriene A4 Hydrolase App 20200308181 - Arnaiz; Damian O. ;   et al. | 2020-10-01 |
Digital Footprint Visual Navigation App 20200304592 - Park; Jason ;   et al. | 2020-09-24 |
Privacy Scout App 20200202037 - Parkinson; John ;   et al. | 2020-06-25 |
Embedded virtual private network App 20200106746 - Park; Jason ;   et al. | 2020-04-02 |
Authenticating Devices Via Tokens and Verification Computing Devices App 20200092283 - Parkinson; John ;   et al. | 2020-03-19 |
Digital Visualization and Perspective Manager App 20190362069 - Park; Jason ;   et al. | 2019-11-28 |
Diamine Derivatives As Inhibitors Of Leukotriene A4 Hydrolase App 20180230159 - Arnaiz; Damian O. ;   et al. | 2018-08-16 |
Diamine Derivatives As Inhibitors Of Leukotriene A4 Hydrolase App 20160272649 - Arnaiz; Damian O. ;   et al. | 2016-09-22 |
Diamine derivatives as inhibitors of leukotriene A4 hydrolase Grant 9,315,509 - Arnaiz , et al. April 19, 2 | 2016-04-19 |
Diamine Derivatives As Inhibitors Of Leukotriene A4 Hydrolase App 20150080382 - Arnaiz; Damian O. ;   et al. | 2015-03-19 |
Diamine derivatives as inhibitors of leukotriene A4 hydrolase Grant 8,569,303 - Arnaiz , et al. October 29, 2 | 2013-10-29 |
Diamine Derivatives As Inhibitors Of Leukotriene A4 Hydrolase App 20130123243 - Arnaiz; Damian O. ;   et al. | 2013-05-16 |
Intermediates for the preparation of lipoxin A.sub.4 analogs Grant 7,928,255 - Bauman , et al. April 19, 2 | 2011-04-19 |
Diamine Derivatives as Inhibitors of Leukotriene A4 Hydrolase App 20100210630 - Arnaiz; Damian ;   et al. | 2010-08-19 |
Diamine derivatives as inhibitors of leukotriene A.sub.4 hydrolase Grant 7,737,145 - Arnaiz , et al. June 15, 2 | 2010-06-15 |
Treatment and prevention of intestinal fibrosis App 20080119439 - Parkinson; John ;   et al. | 2008-05-22 |
Modulation of MDL-1 activity for treatment of inflammatory disease App 20070179094 - Faulds; Daryl ;   et al. | 2007-08-02 |
Diamine derivatives as inhibitors of leukotriene A4 hydrolase App 20070155726 - Arnaiz; Damian ;   et al. | 2007-07-05 |
Amide inhibitors of leukotriene A4 hydrolase App 20070155727 - Chen; Ming ;   et al. | 2007-07-05 |
N-heterocyclic derivatives as NOS inhibitors Grant 6,887,865 - Arnaiz , et al. May 3, 2 | 2005-05-03 |
N-heterocyclic derivatives as NOS inhibitors Grant 6,864,263 - Arnaiz , et al. March 8, 2 | 2005-03-08 |
N-heterocyclic derivatives as NOS inhibitors Grant 6,864,368 - Arnaiz , et al. March 8, 2 | 2005-03-08 |
N-heterocyclic derivatives as NOS inhibitors Grant 6,849,739 - Arnaiz , et al. February 1, 2 | 2005-02-01 |
N-heterocyclic derivatives as NOS inhibitors Grant 6,846,829 - Arnaiz , et al. January 25, 2 | 2005-01-25 |
N-heterocyclic derivatives as NOS inhibitors Grant 6,841,674 - Arnaiz , et al. January 11, 2 | 2005-01-11 |
N-heterocyclic derivatives as nos inhibitors Grant 6,841,673 - Arnaiz , et al. January 11, 2 | 2005-01-11 |
N-heterocyclic derivatives as NOS inhibitors Grant 6,747,031 - Arnaiz , et al. June 8, 2 | 2004-06-08 |
N-heterocyclic derivatives as NOS inhibitors Grant 6,670,473 - Arnaiz , et al. December 30, 2 | 2003-12-30 |
N-heterocyclic derivatives as NOS inhibitors App 20030092678 - Arnaiz, Damian O. ;   et al. | 2003-05-15 |
N-heterocyclic derivatives as NOS inhibitors App 20030083332 - Arnaiz, Damian O. ;   et al. | 2003-05-01 |
N-heterocyclic derivatives as NOS inhibitors App 20030078265 - Arnaiz, Damian O. ;   et al. | 2003-04-24 |
N-heterocyclic derivatives as NOS inhibitors App 20030073669 - Arnaiz, Damian O. ;   et al. | 2003-04-17 |
N-heterocyclic derivatives as NOS inhibitors App 20030069210 - Arnaiz, Damian O. ;   et al. | 2003-04-10 |
N-heterocyclic derivatives as NOS inhibitors App 20030060452 - Arnaiz, Damian O. ;   et al. | 2003-03-27 |
N-heterocyclic derivatives as NOS inhibitors App 20030027794 - Arnaiz, Damian O. ;   et al. | 2003-02-06 |
N-heterocyclic derivatives as NOS inhibitors App 20030004137 - Arnaiz, Damian O. ;   et al. | 2003-01-02 |
N-heterocyclic derivatives as NOS inhibitors App 20020183323 - Arnaiz, Damian O. ;   et al. | 2002-12-05 |
N-heterocyclic derivatives as NOS inhibitors App 20020165203 - Arnaiz, Damian O. ;   et al. | 2002-11-07 |
N-heterocyclic derivatives as NOS inhibitors Grant 6,432,947 - Arnaiz , et al. August 13, 2 | 2002-08-13 |
SEC | 0001405089 | Parkinson John |
SEC | 0001545365 | Parkinson John |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.